These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 9698084

  • 21. Metabolism of primaquine by liver homogenate fractions. Evidence for monoamine oxidase and cytochrome P450 involvement in the oxidative deamination of primaquine to carboxyprimaquine.
    Constantino L, Paixão P, Moreira R, Portela MJ, Do Rosario VE, Iley J.
    Exp Toxicol Pathol; 1999 Jul; 51(4-5):299-303. PubMed ID: 10445386
    [Abstract] [Full Text] [Related]

  • 22. A and B forms of monoamine oxidase within the monoaminergic neurons of the rat brain.
    Fagervall I, Ross SB.
    J Neurochem; 1986 Aug; 47(2):569-76. PubMed ID: 3734795
    [Abstract] [Full Text] [Related]

  • 23. Stereoselective HPLC-assay for citalopram and its metabolites.
    Zheng Z, Jamour M, Klotz U.
    Ther Drug Monit; 2000 Apr; 22(2):219-24. PubMed ID: 10774637
    [Abstract] [Full Text] [Related]

  • 24. Plasma levels of citalopram enantiomers and metabolites in elderly patients.
    Foglia JP, Pollock BG, Kirshner MA, Rosen J, Sweet R, Mulsant B.
    Psychopharmacol Bull; 1997 Apr; 33(1):109-12. PubMed ID: 9133760
    [Abstract] [Full Text] [Related]

  • 25. Analysis of the enantiomers of citalopram and its demethylated metabolites using chiral liquid chromatography.
    Kosel M, Eap CB, Amey M, Baumann P.
    J Chromatogr B Biomed Sci Appl; 1998 Nov 20; 719(1-2):234-8. PubMed ID: 9869386
    [Abstract] [Full Text] [Related]

  • 26. Biotransformation of xenobiotics by amine oxidases.
    Benedetti MS.
    Fundam Clin Pharmacol; 2001 Apr 20; 15(2):75-84. PubMed ID: 11468017
    [Abstract] [Full Text] [Related]

  • 27. Bromo-dragonfly, a psychoactive benzodifuran, is resistant to hepatic metabolism and potently inhibits monoamine oxidase A.
    Noble C, Holm NB, Mardal M, Linnet K.
    Toxicol Lett; 2018 Oct 01; 295():397-407. PubMed ID: 30036687
    [Abstract] [Full Text] [Related]

  • 28. Lack of adverse interactions between concomitantly administered selegiline and citalopram.
    Laine K, Anttila M, Heinonen E, Helminen A, Huupponen R, Mäki-Ikola O, Reinikainen K, Scheinin M.
    Clin Neuropharmacol; 1997 Oct 01; 20(5):419-33. PubMed ID: 9331518
    [Abstract] [Full Text] [Related]

  • 29. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS.
    Biokhimiia; 1979 Feb 01; 44(2):195-207. PubMed ID: 435561
    [Abstract] [Full Text] [Related]

  • 30. SR 95191, a selective inhibitor of type A monoamine oxidase with dopaminergic properties. II. Biochemical characterization of monoamine oxidase inhibition.
    Kan JP, Steinberg R, Mouget-Goniot C, Worms P, Bizière K.
    J Pharmacol Exp Ther; 1987 Jan 01; 240(1):251-8. PubMed ID: 3100771
    [Abstract] [Full Text] [Related]

  • 31. Identification of three cytochrome P450 isozymes involved in N-demethylation of citalopram enantiomers in human liver microsomes.
    Rochat B, Amey M, Gillet M, Meyer UA, Baumann P.
    Pharmacogenetics; 1997 Feb 01; 7(1):1-10. PubMed ID: 9110356
    [Abstract] [Full Text] [Related]

  • 32. Metabolism of the newer antidepressants. An overview of the pharmacological and pharmacokinetic implications.
    Caccia S.
    Clin Pharmacokinet; 1998 Apr 01; 34(4):281-302. PubMed ID: 9571301
    [Abstract] [Full Text] [Related]

  • 33. Review of pharmacokinetic and pharmacodynamic interaction studies with citalopram.
    Brøsen K, Naranjo CA.
    Eur Neuropsychopharmacol; 2001 Aug 01; 11(4):275-83. PubMed ID: 11532381
    [Abstract] [Full Text] [Related]

  • 34. Cytochrome P450-dependent disposition of the enantiomers of citalopram and its metabolites: in vivo studies in Sprague-Dawley and Dark Agouti rats.
    Kingbäck M, Carlsson B, Ahlner J, Bengtsson F, Kugelberg FC.
    Chirality; 2011 Feb 01; 23(2):172-7. PubMed ID: 20848647
    [Abstract] [Full Text] [Related]

  • 35. A monoamine oxidase-B inhibitor, MD 780236, metabolized essentially by the A form of the enzyme in the rat.
    Strolin Benedetti M, Dow J.
    J Pharm Pharmacol; 1983 Apr 01; 35(4):238-45. PubMed ID: 6133934
    [Abstract] [Full Text] [Related]

  • 36. Fluvoxamine but not citalopram increases serum melatonin in healthy subjects-- an indication that cytochrome P450 CYP1A2 and CYP2C19 hydroxylate melatonin.
    von Bahr C, Ursing C, Yasui N, Tybring G, Bertilsson L, Röjdmark S.
    Eur J Clin Pharmacol; 2000 May 01; 56(2):123-7. PubMed ID: 10877005
    [Abstract] [Full Text] [Related]

  • 37. Effect of long-term treatment with selective monoamine oxidase A and B inhibitors on dopamine release from rat striatum in vivo.
    Lamensdorf I, Youdim MB, Finberg JP.
    J Neurochem; 1996 Oct 01; 67(4):1532-9. PubMed ID: 8858937
    [Abstract] [Full Text] [Related]

  • 38. Different sensitivity of mitochondrial and cytosolic monoamine oxidases to in vivo but not in vitro inhibition by specific irreversible inhibitors.
    Moskvitina TA, Medvedev AE.
    Med Sci Monit; 2001 Oct 01; 7(1):17-9. PubMed ID: 11208486
    [Abstract] [Full Text] [Related]

  • 39. Characterization of 1-Aminobenzotriazole and Ketoconazole as Novel Inhibitors of Monoamine Oxidase (MAO): An In Vitro Investigation.
    Shaik AN, LeDuc BW, Khan AA.
    Eur J Drug Metab Pharmacokinet; 2017 Oct 01; 42(5):827-834. PubMed ID: 28185143
    [Abstract] [Full Text] [Related]

  • 40. Simultaneous analysis of citalopram and desmethylcitalopram by liquid chromatography with fluorescence detection after solid-phase extraction.
    Meng QH, Gauthier D.
    Clin Biochem; 2005 Mar 01; 38(3):282-5. PubMed ID: 15708552
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.